Come for the culture shift, stay for the vision of wellness that isnt just digitalbut deeply human
Sitagliptin and Metformin Immediate-Release Coadministration in Patients with Type 2 Diabetes Inadequately Controlled on Diet and Exercise Table 1 summarizes the most common (5% of patients) adverse reactions reported (regardless of investigator assessment of causality) in a 24-week placebo-controlled factorial study in which sitagliptin and metformin immediate-release were coadministered to patients with type 2 diabetes inadequately controlled on diet and exercise
Insurance coverage for GLP-1 weight loss medications has been expanding, with some states now requiring coverage and new Medicare provisions taking effect
Martell BA, Orson FM, Poling J, et al
By maintaining high levels of glutathione, you provide your body with a buffer against this oxidative stress
Current evidence suggests these medications may actually provide additional mood benefits for individuals with pre-existing conditions